quinuclidines has been researched along with Astrocytoma, Grade IV in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castresana, JS; De La Rosa, J; Idoate, MA; Meléndez, B; Rey, JA; Urdiciain, A; Zazpe, I; Zelaya, MV | 1 |
| Affronti, ML; Friedman, HS; Herndon, JE; Schlundt, S; Schneider, SM | 1 |
| Jean-Claude, B; Mansure, J; Patyka, M; Petrecca, K; Sabri, S; Sharifi, Z | 1 |
| Bria, E; Corona, M; Fabi, A; Lanzetta, G; Minniti, G; Nardoni, C; Restuccia, MR; Rozzi, A | 1 |
1 trial(s) available for quinuclidines and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glioblastoma; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Temozolomide; Vomiting | 2011 |
3 other study(ies) available for quinuclidines and Astrocytoma, Grade IV
| Article | Year |
|---|---|
APR-246 combined with 3-deazaneplanocin A, panobinostat or temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Colony-Forming Units Assay; Drug Screening Assays, Antitumor; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mutation; Panobinostat; Quinuclidines; Temozolomide; Tumor Suppressor Protein p53 | 2021 |
Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.
Topics: Adult; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Dexamethasone; Female; Glioblastoma; Humans; Isoquinolines; Male; Medication Adherence; Middle Aged; Nausea; Neoplasms; Palonosetron; Quality of Life; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Translational Research, Biomedical; Treatment Outcome; Vomiting | 2014 |
Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.
Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; DNA Modification Methylases; DNA Repair Enzymes; Extracellular Signal-Regulated MAP Kinases; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mutation; Neoplastic Stem Cells; Nuclear Proteins; Phosphorylation; Quinuclidines; RNA Interference; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2016 |